Navigation Links
Boston Scientific Announces Results for First Quarter Ended March 31, 2011
Date:4/20/2011

restructuring charges associated with the Company's 2010 Restructuring plan and Plant Network Optimization program;
  • $4 million of discrete tax items related to certain tax positions taken in a prior period; and
  • $114 million ($132 million pre-tax) of amortization expense.

  • Adjusted net income for the first quarter of 2011, excluding these net charges, was $336 million, or $0.22 per share.

    On a GAAP basis, net loss for the first quarter of 2010 was $1.589 billion, or $1.05 per share, and was driven primarily by a goodwill impairment charge related to the Company's U.S. CRM business unit. Reported results included goodwill and intangible asset impairment charges; acquisition-, divestiture-, and restructuring-related net charges and amortization expense (after-tax) of $1.840 billion, or $1.21 per share. Adjusted net income for the first quarter of 2010, excluding these net charges, was $251 million, or $0.16 per share.

    Guidance for Second Quarter and Full Year 2011The Company estimates net sales for the second quarter of 2011 in a range of $1.92 to $2.0 billion.  Compared to net sales for the second quarter of 2010, this range assumes a $46 million negative impact from the divestiture of the Neurovascular business.  The Company estimates earnings on a GAAP basis in a range of $0.05 to $0.08 per share. Adjusted earnings, excluding acquisition-, divestiture- and restructuring-related net charges and amortization expense, are estimated in a range of $0.12 to $0.15 per share. Recent acquisitions are expected to dilute second quarter 2011 adjusted earnings by approximately $0.01 per share as compared to the prior year, and the divestiture of the Neurovascular business is expected to dilute second quarter 2011 adjusted earnings by $0.01 per share.

    The Company now estimates net sales for the full year 2011 in a range of $7.6 to $7.9 billion.  Compared to full year 2010 net sales, this range now assumes a $212
    '/>"/>

    SOURCE Boston Scientific Corporation
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

    Related medicine technology :

    1. Dainippon Sumitomo Pharma Co., Ltd. and Boston Biomedical, Inc. Enter Strategic Partnership on Anti-Cancer Drugs Targeting Cancer Stem Cells
    2. Boston Scientific Begins International Clinical Trial Enrollment for INNOVA™ Self-Expanding Bare-Metal Stent System
    3. Boston Scientific ION™ Platinum Chromium Stent System Demonstrates Strong Performance in Analysis of PERSEUS and TAXUS ATLAS Clinical Trial Data
    4. Hologic, Hospira, Boston Scientific, Allergan to Participate in Leading Medical Device Manufacturing Symposium
    5. Boston Scientific Announces Its ACC 2011 Schedule
    6. Boston Scientific Receives FDA Approval of New Clik(TM) Anchor for Precision Plus(TM) Spinal Cord Stimulator System
    7. Boston Scientific to Webcast Analyst Event
    8. Boston Scientific to Present at Barclays Capital 2011 Global Healthcare Conference
    9. Boston Scientific Announces European Approval and Launch of OMEGA™ Platinum Chromium Stent System
    10. Unilife to Present at the 31st Annual Cowen Health Care Conference on Wednesday, March 9, 2011 in Boston
    11. Boston Scientific Strengthens Structural Heart Product Portfolio By Completing Acquisition of Atritech
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/22/2014)... Cyberonics, Inc. (NASDAQ: CYBX ), a global leader ... today announced it will participate in the 33 rd ... in San Francisco . ... speak at 11:00 AM Pacific Time.  A live audio webcast ... Investor Relations link on the Cyberonics home page at ...
    (Date:12/22/2014)... Dec. 22, 2014  Mark Farrah Associates (MFA), ... a summary of the 2015 marketplace exchange projections ... According to a recent ASPE ... Evaluation, Department of Health and Human Services) report, ... individual medical plans through the Marketplace as of ...
    (Date:12/22/2014)...  Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage ... chronic pain, announced today that the first cohort ... and pharmacodynamic study with d-Methadone, the company,s N-methyl-D-aspartate ... Racemic methadone is a long-acting opioid used in ... therapy in opioid addiction.  It is constituted by ...
    Breaking Medicine Technology:Insights into the Marketplace and Individual Market Growth 2Relmada Therapeutics Doses First Cohort of Subjects in Human Clinical Trial of d-Methadone 2Relmada Therapeutics Doses First Cohort of Subjects in Human Clinical Trial of d-Methadone 3
    ... Isotopes Inc (OTC Bulletin Board: INIS ) announces ... general business status, particularly, the year to date performance of ... of its ongoing plans for the depleted uranium de-conversion project. ... When: Wednesday, September 14 – 3:00PM ...
    ... 2011 The Educational Review System announces the pediatric ... Gaps — Where do we go from here?" – ... first annual Pediatric Medication Safety Summit, will focus on ... benefits of technology and the gaps. ...
    Cached Medicine Technology:International Isotopes Inc Announces Conference Call to Give an Update on the Company's General Business Status 2
    (Date:12/22/2014)... Physicians in China are most eagerly awaiting ... non-Hodgkin’s lymphoma (NHL), according to a new report from ... firm. MabThera is the only biologic available to treat ... of NHL. , According to Kantar Health’s report, “Biosimilars ... NHL in China has been growing and is expected ...
    (Date:12/22/2014)... Only weeks following the announcement that ... to have a battery manufacturer create 29 well-paying jobs ... ) is launching in Henderson to deliver yet ... strong manufacturing sector is going to build a stronger ... “and TalkLocal works with small businesses that rely on ...
    (Date:12/22/2014)... Pasadena, CA (PRWEB) December 22, 2014 ... is now offering consultations for sleep apnea. Drowsy drivers ... crashes than drivers who are well-rested, and some experts ... on the roads as intoxicated drivers. Unfortunately, millions of ... to the American Academy of Sleep Medicine, about 18 ...
    (Date:12/22/2014)... Luxury Linen purveyor Peacock Alley once again joined ... logistics and support for one of Dallas’ largest holiday toy ... of giving back to the community in which it lives ... were Whataburger® and 99.5 The Wolf. , There is no ... to children who would otherwise not receive any is a ...
    (Date:12/22/2014)... 21, 2014 A substantial percentage ... computed tomography (CT) to evaluate abnormal findings on ... cancer, according to a new study published online ... the findings show that radiologist recommendations for additional ... to patient care. , RAIs, which have grown ...
    Breaking Medicine News(10 mins):Health News:Physicians in China See Most Significant Demand for MabThera Biosimilar 2Health News:Physicians in China See Most Significant Demand for MabThera Biosimilar 3Health News:TalkLocal Launches in Henderson Weeks Following New Megafactory, New Jobs Announcement 2Health News:Pasadena Dentist, Dr. Marine Martirosyan, Now Offers Consultations for Sleep Apnea 2Health News:Peacock Alley and Community Partners of Dallas Fulfill an Estimated 12,000 Holiday Wishes for Deserving Children 2Health News:RSNA: Radiologist Recommendations for Chest CT Have High Clinical Yield 2Health News:RSNA: Radiologist Recommendations for Chest CT Have High Clinical Yield 3
    ... Once-daily Keppra XR(TM) (levetiracetam) extended-release tablets are now ... to simplify patients, treatment plans by decreasing the ... (Photo: http://www.newscom.com/cgi-bin/prnh/20090410/NY97244 )According to studies published ... Neurology , patients are more likely to adhere ...
    ... Tenn., April 10 ProLogis (NYSE: PLD ... today that it has leased approximately 211,000 square feet ... global provider of products and services that improve the ... the space at ProLogis Park DeSoto, a master-planned distribution ...
    ... Dr. Ashish K. Jha of the Harvard School of Public Health ... ... Washington, DC (PRWEB) April 10, 2009 -- Leroy Jones, ... Washington, D.C., has recorded another episode of his podcast series, "Talking ...
    ... sport-specific eyewear to prevent devastating injuriesAUSTIN, Texas, April 9 ... routine basketball game his senior year of high school turned ... who played years of hoops without any injuries. But when ... Stephen ended up with a large laceration on his left ...
    ... LLP, a San Francisco, California-based trial law firm, filed the first ... Raptiva medication. Filed in Alameda Superior Court, the complaint seeks ... ... (PRWEB) April 9, 2009 -- Audet & Partners, LLP , ...
    ... one of 14 given recent warning, will remain on the ... Bowing to the pleas of hospice experts, the U.S. Food ... from the market an unapproved liquid morphine painkiller given to ... the FDA,s Center for Drug Evaluation and Research, told the ...
    Cached Medicine News:Health News:New Keppra XR(TM) Dosage Strength Offers Simplified Treatment Option for People Living With Partial-Onset Seizures 2Health News:New Keppra XR(TM) Dosage Strength Offers Simplified Treatment Option for People Living With Partial-Onset Seizures 3Health News:New Keppra XR(TM) Dosage Strength Offers Simplified Treatment Option for People Living With Partial-Onset Seizures 4Health News:ProLogis Leases 211,000 Square Feet to Cardinal Health Near Memphis 2Health News:New Interview on E-Health Records with Dr. Ashish K. Jha of the Harvard School of Public Health on Talking Technology 2Health News:Eye Protection is Essential for Texas Athletes 2Health News:Eye Protection is Essential for Texas Athletes 3Health News:Audet & Partners, LLP Files First Raptiva Lawsuit After Announced Withdrawal 2Health News:Audet & Partners, LLP Files First Raptiva Lawsuit After Announced Withdrawal 3Health News:FDA Reverses Stance on Removal of Morphine Painkiller 2
    Cytomegalovirus IgM ELISA....
    Small Incision Microforceps: Tano ILM Forceps...
    Blunt tipped forceps with a thin tip angled at approximately 135 and hollowed out "notch" on the interior of the distal end. Tip is shaped like a pic when in the closed position. For membrane peeling...
    Microforceps: Claes ILM Forceps...
    Medicine Products: